...
首页> 外文期刊>Expert opinion on drug delivery >Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
【24h】

Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB

机译:通过肺药输送系统选择性药物沉积肺部抗药性TB的有效管理

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) is a major health issue and continues to be a global health concern. Despite significant advancements in treatment modalities, similar to 1.6 million deaths worldwide occur due to TB infection. This is because of tuberculosis reservoirs in the alveoli making it a challenge for the formulation scientist to target this.
机译:介绍:多药结核病(MDR-TB)的出现和广泛的耐药结核(XDR-TB)是一个主要的健康问题,并持续成为全球性健康问题。 尽管治疗方式有重大进展,但由于TB感染导致全世界的60万人死亡。 这是因为肺泡中的结核水库,使其成为制定科学家瞄准这一目标的挑战。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号